Detalhe da pesquisa
1.
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
N Engl J Med
; 367(9): 805-16, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931314
2.
NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
J Immunol
; 190(9): 4650-60, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23554313
3.
Donor activating KIR2DS1 in leukemia.
N Engl J Med
; 371(21): 2042, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409391
4.
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice.
Front Immunol
; 11: 888, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477359
5.
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
Front Immunol
; 8: 1444, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29163516
6.
Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
J Gastrointest Oncol
; 8(6): 1079-1099, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299370
7.
Intravenous neridronate for skeletal damage treatment in patients with multiple myeloma.
Acta Biomed
; 77(2): 81-4, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17172186
8.
Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.
Front Immunol
; 6: 230, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26029215
9.
Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases.
Clin Med Insights Blood Disord
; 8: 1-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26052230
10.
Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies.
Front Immunol
; 5: 95, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24672522
11.
Enhanced cytotoxic activity of ex vivo-differentiated human natural killer cells in the presence of HOXB4.
J Immunother
; 37(5): 278-82, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24810639
12.
Editorial: Tailoring NK Cell Receptor-Ligand Interactions: An Art in Evolution.
Front Immunol
; 9: 351, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535727
13.
Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy.
Clin Cancer Res
; 17(9): 2628-37, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21224372